GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 13, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on May 13, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases and does not indicate any new or significant risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker
- May 13, 2025 (date) — Date of announcement
FAQ
What was the specific number of ordinary shares purchased by GSK plc?
The filing states that GSK plc purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What was the total dollar amount spent on the share repurchase?
The filing does not disclose the total dollar amount of the share repurchase.
Who acted as GSK's corporate stockbroker for this transaction?
Citigroup Global Markets Limited acted as GSK's corporate stockbroker.
On what date did GSK plc announce this transaction?
GSK plc announced the transaction on May 13, 2025.
What is the par value of GSK's ordinary shares?
The ordinary shares are of 31¼ pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 13, 2025 regarding GSK plc (GLAXF).